Veterinary Medicine Pefloxacin Mesylate Powder CAS 70458-95-6 Raw Materials

CAS:  70458-95-6

MF: C18H24FN3O6S

MW: 429.46

EINECS: 274-613-9

Specification​: 99% min Pefloxacin Mesylate

Sample: Pefloxacin Mesylate Powder

Packaging:1kg/bag, 25kg/drum

Brand: Henrikang

Appearance: White Powder

Storage: Cool Dry Place

Shelf Life: 2 Years

Test Method: HPLC

Portal:https://henrikang.en.made-in-china.com/

Pefloxacin Mesylate Powder Usage and Synthesis.

Pefloxacin Mesylate Powder is a fluoroquinolone antibacterial agent with the characteristics of broad antibacterial spectrum, strong activity, rapid absorption, and easy use. Pefloxacin Mesylate Powder is a fluoroquinolone antibacterial agent with the characteristics of broad antibacterial spectrum, strong activity, rapid absorption, and easy use.

Veterinary Medicine Pefloxacin Mesylate against Gram-negative and Gram-positive bacteria, Pefloxacin Mesylate Raw Materials include Enterobacteriaceae, Pseudomonas aeruginosa, Acinetobacter SPP., Haemophilus SPP.

Neisseria species and Staphylococcus species, including methicillin-resistant bacteria. Neisseria species and Staphylococcus species, including methicillin-resistant strains, have broad spectrum activity.

Uses and functions of Pefloxacin Mesylate Powder.

Pefloxacin Mesylate belongs to the fluoroquinolone group of antibacterial drugs, which has the characteristics of broad spectrum of antibacterial activity, strong vitality, fast absorption and easy to use. It has broad-spectrum activity against Gram-negative and Gram-positive bacteria, including Enterobacteriaceae, Pseudomonas aeruginosa, Actinobacillus, Haemophilus, Neisseria and Staphylococcus (including methicillin-resistant strains).

It is similar to vancomycin in its anti-glucose properties, and is also effective against some multi-resistant strains and methicillin-resistant bacteria. For penicillin G, benzathine penicillin-resistant Staphylococcus aureus, pefloxacin is generally sensitive to it.

Its antibacterial spectrum is wide, antibacterial activity is strong, the mode of action is to inhibit the bacterial DNA promoter enzyme, multi-drug-resistant bacteria (including hospital strains) on pefloxacin has no cross-resistance.

The efficacy of Pefloxacin on certain severe infections is comparable or superior to that of third and fourth generation cephalosporins, new aminoglycoside antibiotics and ciprofloxacin.

Currently, Pefloxacin plays an important role in the antimicrobial therapy of various septic infectious diseases, especially central nervous system infections, cardiovascular infections, respiratory infections, gynecological infections and bone infections.

Infections caused by Pefloxacin-susceptible organisms: urinary tract infections; respiratory tract infections; ear, nose and throat infections; gynecological and reproductive infections; abdominal and hepatic and biliary infections; bone and joint infections; skin infections; sepsis and endocarditis; meningitis.

Pharmacological Effects of Pefloxacin Mesylate Powder.

Because serious adverse reactions have been reported with the use of fluoroquinolones, including Pefloxacin Mesylate Powder for Injection, and because acute bacterial sinusitis, acute exacerbation of chronic bronchitis, simple urinary tract infections, and acute uncomplicated cystitis are self-limiting in some patients, Pefloxacin Mesylate Powder for Injection should be used only in the absence of other medications.

Production method of Pefloxacin Mesylate Powder.

Pefloxacin Mesylate is a synthetic chemotherapeutic and antimicrobial agent with an IC50 of 6.7 nM.